128459-27-8 Usage
Structure
Derived from the camphanic acid ring system and the sugar alcohol myo-inositol
Function
Alpha-glucosidase inhibitor
Medical Use
Treatment of type 2 diabetes
Mechanism of Action
Slows down digestion and absorption of carbohydrates in the intestines
Mode of Action
Inhibits enzymes that break down complex sugars into simple sugars
Effect
Delays release of glucose into the bloodstream after a meal
Clinical Impact
Helps control blood glucose levels and prevent rapid spikes in blood sugar levels after eating
Importance
Essential for managing diabetes and reducing the risk of complications associated with the disease
Check Digit Verification of cas no
The CAS Registry Mumber 128459-27-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,4,5 and 9 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 128459-27:
(8*1)+(7*2)+(6*8)+(5*4)+(4*5)+(3*9)+(2*2)+(1*7)=148
148 % 10 = 8
So 128459-27-8 is a valid CAS Registry Number.
128459-27-8Relevant articles and documents
Efficient and systematic syntheses of enantiomerically pure and regiospecifically protected myo-inositols
Bruzik, Karol S.,Tsai, Ming-Daw
, p. 6361 - 6374 (2007/10/02)
Efficient and systematic syntheses of a variety of enantiomerically pure and regiospecifically protected myo-inositols, which can be readily used as precursors for most natural and unnatural derivatives of myo-inositol, have been developed. The key strate
Expedient Synthesis of D-myo-Inositol 1,4,5-Trisphosphate and D-myo-Inositol 1,4-Bisphosphate
Salamonczyk, Grzegorz M.,Pietrusiewicz, K. Michal
, p. 6167 - 6170 (2007/10/02)
Readily available selfresolving myo-inositol D-camphor 2,3-monoacetal is converted into the title inositol phosphates by the concise procedures utilizing 1,4,5-selective tris-acylation and 1,4-selective bis-silylation of the starting tetrol in the key ste